Shear-wave elastography: a new potential method to diagnose ulnar neuropathy at the elbow

Cubital tunnel syndrome, also referred to as ulnar neuropathy at the elbow (UNE), is the second most common peripheral entrapment neuropathy after carpal tunnel syndrome. It can be defined as a compression of the ulnar nerve at the level of the elbow or in its direct proximity [1‐4]. The ulnar nerve may be compressed at the cubital tunnel inlet by the medial intermuscular septum and an aponeurotic band referred to as the arcade of Struthers. Moreover, the nerve may be entrapped in the tunnel by the Osborne's band, a retinaculum that extends from the medial epicondyle to the olecranon, and by the aponeurosis of the flexor carpi ulnaris (FCU); this is postulated to be the most common site of the entrapment [5‐7]. Finally, the ulnar nerve may be compressed distally, at the tunnel outlet, by the two heads of the FCU muscle [7].

Idiopathic neuropathy seems to be the most common cause of UNE among many potential aetiological factors of this condition [7, 8]. Ulnar neuropathy may also result from habitual elbow flexion, acute or repetitive trauma, excessive strain, presence of mass-like lesions, degenerative arthritis and snapping triceps syndrome. The list of intrinsic aetiological factors includes diseases of the thyroid, diabetes mellitus, alcohol abuse, rheumatoid arthritis and other systemic inflammatory diseases, to mention a few [5, 7, 9‐11].

Because of its high incidence in the general population and a broad spectrum of symptoms that may interfere with patients’ ability to work and their activities of daily living, UNE constitutes a significant clinical problem [7, 8, 12]. A number of healthcare professionals with various specialities, among them general practitioners, plastic surgeons, orthopaedic surgeons and neurologists, are involved in the evaluation of UNE. Although no consensus regarding a management algorithm for UNE has been reached thus far, a recent meta-analysis conducted by Mowlavi et al. demonstrated that clinical work-up is crucial to establish the diagnosis, to determine the severity of ulnar neuropathy and to choose an appropriate treatment strategy [12]. The diagnosis is based primarily on detailed analysis of medical history and physical examination. According to many authors, electrodiagnostic studies constitute an essential component of the evaluation, as they can be used to confirm the diagnosis and to assess the severity of nerve damage. Additional tests, such as ultrasonography (US), plain film radiography and magnetic resonance imaging (MRI), are recommended in patients with vague clinical presentation or during preoperative work-up [1, 5‐7, 13‐25]. Based on published evidence we can expect that also diffusion tensor imaging may be soon added to the peripheral nerve assessment armamentarium [26‐31].

During recent years, sonoelastography, a relatively new imaging technology to quantify tissue stiffness, has been gaining a growing interest of researchers and healthcare professionals. Since its introduction by Ophir and colleagues in 1991, sonoelastography has evolved considerably and found application in many clinical disciplines; other potential uses of sonoelastography are still a subject of ongoing research [32, 33]. One highly promising application of sonoelastography, in particular shear-wave elastography (SWE), is the evaluation of peripheral nerve elasticity in patients with entrapment syndromes. Several authors reported the use of elastography in the diagnosis of median, sciatic and tibial compressive neuropathies [34‐43]. However, to the best of our knowledge, potential application of this technique as a method to detect UNE has not been studied thus far.

The aim of this study was to use SWE for the quantification of ulnar nerve elasticity in patients with UNE and in healthy controls, and to verify if this technique may find application in clinical practice as an instrument to detect compressive neuropathy.

UNE group included 34 patients with mean age of 59.35 years (range, 36-85 years), among them six men (mean age, 62 years; range, 48-85 years) and 28 women (mean age, 58,79 years; range, 36-80 years), with confirmed ulnar compressive neuropathy at the elbow level. Control group comprised 38 healthy volunteers with mean age of 57.42 years (range, 38-84 years), among them three men (mean age, 53.67 years; range, 38-75 years) and 35 women (mean age, 57.74 years; range, 38-84 years), in whom UNE was excluded based on the results of physical examination and EDX.

The CSA of the ulnar nerve at the cubital tunnel level turned out to be significantly larger in patients with UNE than in the controls (mean, 9.03 mm²; median, 8 mm²; range, 5-18 mm² vs. mean, 6.47 mm²; median, 6 mm²; range, 3-9 mm²; p < 0.001). The cut-off value for the CSA of the ulnar nerve at the cubital tunnel level, which most accurately distinguished between the individuals with the entrapment neuropathy and without was 10 mm²; ROC analysis demonstrated that this value provided 38.2% sensitivity, 100% specificity, 100% PPV and 64.4% NPV in the detection of UNE (Fig. 3).

The results of SWE measurements are summarised in Table 2. In any patient the differences between measurements that were repeated at each level with 3 minutes intervals did not exceed 2 kPa (SD ≥ 1.15). Compared to the controls, patients with UNE presented with significantly greater ulnar nerve stiffness at each examined level. In the UNE group, mean ulnar nerve stiffness at the entrapment site in the cubital tunnel (96.38 kPa) was significantly greater than at the distal arm and mid-arm (38.79 kPa and 39.06 kPa, respectively; p < 0.001). In the healthy controls, no statistically significant differences were found in ulnar nerve stiffness at various levels (p = 0.779).

Aside from the comparison of crude SWE parameters for the entrapment site, we also analysed their normalised values, obtained by dividing ulnar nerve stiffness at the cubital tunnel level (CT) by its stiffness at the distal arm (CT to DA ratio) or mid-arm (CT to MA ratio). The values of both ratios turned out to be significantly higher in patients with UNE than in the controls (p < 0.001) (Table 3).

ROC curves illustrating the diagnostic accuracy of elastographically determined ulnar nerve stiffness at the cubital tunnel level, CT to DA and CT to MA ratios in the detection of UNE are presented in Fig. 3. Ulnar nerve stiffness at the cubital tunnel level equal 61 kPa provided 100% specificity, sensitivity, PPV and NPV in the detection of UNE. Equally excellent indices of diagnostic accuracy were also obtained for the CT to DA ratio of 1.68, and CT to MA ratio of 1.75 (Fig. 3).

A weak positive correlation was found in the UNE group between the CSA of the ulnar nerve and its stiffness at the site of compression (R = 0.31, p = 0.008). Moreover, the CSA of the ulnar nerve correlated significantly with the values of CT to DA (R = 0.31, p = 0.007) and CT to MA ratios (R = 0.30, p = 0.010).

We hypothesised that SWE can be used for an objective evaluation of oedema and fibrosis associated with ulnar nerve compression. The study showed clearly that patients with UNE presented with significantly greater ulnar nerve stiffness at the cubital tunnel level than healthy controls (mean, 96.38 kPa vs. 33.08 kPa). Furthermore, stiffness of the ulnar nerve in UNE patients turned out to be significantly greater at the entrapment site than at the mid- and distal arm; however, a similar relationship was not observed in the controls. ROC analysis demonstrated that UNE could be accurately diagnosed whenever stiffness of the ulnar nerve at the entrapment site equalled 61 kPa or more. However, recall that ulnar nerve stiffness may vary from patient to patient due to the modulatory effect of additional factors, such as sex, age, BMI, occupation, and upper limb physiognomy. Thus, to boost the diagnostic accuracy of SWE, instead of using the crude value of ulnar nerve stiffness at the entrapment site, we recommend a normalised value of this parameter; dividing ulnar nerve stiffness at the entrapment site by the stiffness of its intact segment, one can eliminate individual variability in the elastographic parameters. In this study, we divided ulnar nerve stiffness at the entrapment site by its stiffness at the distal and mid-arm, obtaining CT to DA and CT to MA ratios, respectively. Similar to the crude value of ulnar nerve stiffness, also the values of both ratios were significantly higher in patients with CTS than in the controls. Moreover, ROC analysis demonstrated that the cut-off values for CT to DA and CT to MA ratios (1.68 and 1.75, respectively) accurately distinguished between patients with compressive ulnar neuropathy and without.

As mentioned before, the diagnosis of UNE is based primarily on medical history and physical examination. Although this diagnosis is usually confirmed by EDX, US due to recent implementation of high-frequency transducers enabling high-resolution images of peripheral nerves is emerging as a complementary method to evaluate patients with compressive neuropathies, e.g. UNE [5, 7, 15, 17, 22‐25, 44, 45]. The hallmark sonographic features of entrapment neuropathy include enlargement of the nerve, its hypoechoic swelling proximal to the compression site, loss of normal fascicular pattern and, not infrequently, oedema of adjacent soft tissues [7, 13, 20, 22, 23]. US is also suitable for the detection of space-occupying masses. Importantly, during the examination, ultrasonographic images of the affected limb can be compared with those of the contralateral extremity. High-resolution US was shown to be more cost- and time-effective than MRI, and its availability is markedly higher. Noticeably, US can be used for both static and dynamic assessment of the ulnar nerve; this may be particularly helpful in patients with nerve subluxation or snapping triceps syndrome [5, 7]. Previous studies demonstrated that ultrasonographically determined ulnar nerve CSA was a feasible indicator for UNE [5, 25, 46]; ulnar nerve CSA at the elbow level equal to 8.3 mm² provided high specificity and sensitivity in the detection of ulnar nerve entrapment [5, 17, 24, 25]. Our findings seem to be consistent with these observations. Not only did the mean CSA of the ulnar nerve at the cubital tunnel level turn out to be significantly larger in patients with UNE than in healthy controls (9.03, range, 5-18 mm² vs. 6.47, range, 3-9 mm²), but also a significant positive correlation was found between this parameter and the elastographically determined ulnar nerve stiffness at the entrapment site. The latter observation seems to confirm the applicability of SWE to UNE diagnosis. The principal drawback of peripheral nerve ultrasonography is the lack of a standardised examination protocol (examination technique, type of transducer, wave frequency) [7]. Moreover, the examination is to a large degree operator-dependent, and thus, its result can be considered reliable only if conducted by an experienced examiner.

Our findings are consistent with the results of other studies that analysed potential application of elastography in the evaluation of compression neuropathies; also, those studies demonstrated that compression may contribute to greater stiffness of the entrapped nerve [34‐43]. In our opinion, SWE constitutes a valuable supplement to ultrasonographic examination of peripheral nerves, also in patients with UNE [14]. Elastography is both a time- and cost-effective method with a relatively steep learning curve. Elastographic findings add considerably to the results of US, providing quantitative data on the nerve stiffness during both static and dynamic examination. In addition, it can determine the level of nerve entrapment. In the future, with its growing availability in routine clinical practice, SWE may be used for the monitoring of treatment outcomes in UNE patients. The numerous advantages of SWE make it a perspective screening tool for early detection of compressive neuropathies, with potential application in occupational medicine. Prompt introduction of adequate preventive measures in persons at risk or implementation of conservative treatment in individuals with early stages of the neuropathy may prevent its long-term consequences, such as chronic disability.

The main limitation of this study may stem from the fact that ulnar nerve stiffness was determined by one radiologist, and thus, we were unable to estimate inter-observer reliability of the results. During the course of another study, which is soon to be conducted at our centre, we will analyse both inter- and intra-observer reliability of SWE measurements taken at various levels of ulnar and median nerves. Interestingly, patients from UNE group presented with significantly greater ulnar nerve stiffness proximally to the compression site than the controls. Because of the preliminary characteristic of our study and lack of evidence from similar study, we are unable to provide an unequivocal explanation for this phenomenon. The exact pathophysiology of compressive neuropathy is still not fully understood. It is commonly accepted that increased pressure on a peripheral nerve affects its microcirculation and, therefore, blood supply. Resultant epineural ischaemia contributes to impaired venous outflow and stasis. Chronic compression may predispose to capillary leakage and neural oedema, which further aggravates the harmful effects of the primary causal factor. With time, this mechanism induces inflammation, fibrosis, demyelination and eventually, after a remyelination failure, axonal integrity loss [7, 47‐49]. Perhaps, this process involves the segment located proximally to the compression site to a larger degree than previously supposed, which manifests as greater stiffness of the nerve, likewise in our series. This would suggest that elastography may be a highly sensitive test to detect structural anomalies in peripheral nerves. This issue definitively needs to be addressed in future studies.

The results of this preliminary study justify further research on the application of SWE as a diagnostic instrument in ulnar neuropathies. The future studies should involve larger groups of patients and verify whether SWE is suitable for the staging of ulnar nerve dysfunction and if the elastographic indices correlate with the routinely used EDX-based scale of UNE severity. Moreover, future research should corroborate if elastography could be used as a screening tool for peripheral neuropathies and whether it may find application as a method to monitor the treatment outcomes.

To summarise, this study demonstrated for the first time that shear wave elastography can be used to diagnose cubital tunnel syndrome. Patients with entrapment syndrome presented with significantly greater ulnar nerve stiffness at the elbow level than healthy controls. These findings imply that SWE has a potential to become a routine diagnostic instrument to detect ulnar neuropathy in a clinical setting.